What is the recommended dosing for Losartan (angiotensin II receptor antagonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Losartan Dosing Recommendations

The standard dosing for losartan is 50 mg once daily initially, with titration to a maximum of 100 mg once daily as needed for blood pressure control in hypertension. 1

Standard Dosing for Different Indications

Hypertension

  • Initial dose: 50 mg once daily
  • Maximum dose: 100 mg once daily
  • Special populations: 25 mg starting dose for patients with possible intravascular depletion (e.g., on diuretic therapy) 1

Hypertensive Patients with Left Ventricular Hypertrophy

  • Initial dose: 50 mg once daily
  • Titration: Can increase to 100 mg once daily based on blood pressure response
  • Combination therapy: Hydrochlorothiazide 12.5 mg daily can be added and increased to 25 mg daily as needed 1

Nephropathy in Type 2 Diabetic Patients

  • Initial dose: 50 mg once daily
  • Maximum dose: 100 mg once daily 1

Heart Failure

  • Higher doses (up to 150 mg daily) may provide greater benefits in heart failure patients, with a 10% relative risk reduction in death or heart failure hospitalization compared to lower doses 2

Dosing in Special Populations

Hepatic Impairment

  • Mild to moderate impairment: 25 mg once daily starting dose
  • Severe impairment: Not studied, use with caution 1

Renal Impairment

  • No dosage adjustment necessary for various degrees of renal insufficiency 3
  • Losartan has been shown to be effective and well-tolerated in patients with chronic renal disease, including those on hemodialysis 4

Pediatric Patients

  • Starting dose: 0.7 mg/kg once daily (up to 50 mg total)
  • Maximum dose: 1.4 mg/kg daily (not to exceed 100 mg)
  • Not recommended for children under 6 years or with eGFR <30 mL/min/1.73m² 1

Dosing Considerations and Monitoring

  • Losartan can be administered without regard to food 3
  • Monitor blood pressure within 1-2 weeks after initiation or dose changes 2
  • Monitor renal function when starting therapy or changing doses 2
  • The pharmacokinetics of losartan are linear and dose-proportional 3
  • Losartan is rapidly absorbed, reaching maximum concentrations 1-2 hours post-administration 3

Clinical Pearls

  • While 50 mg is the standard starting dose, evidence suggests that 100 mg may provide optimal benefits for blood pressure control and renoprotection 2, 5
  • In diabetic nephropathy, 100 mg daily was significantly more effective than 50 mg in reducing albuminuria (48% vs. 30% reduction) 6
  • Losartan is contraindicated in pregnancy 3
  • The active metabolite E3174 is 10-40 fold more potent than losartan with a half-life of 6-9 hours 3
  • Losartan has minimal drug interactions and does not interact with hydrochlorothiazide, warfarin, or digoxin 3

Common Pitfalls to Avoid

  • Underdosing: The 50 mg dose may be insufficient for optimal clinical benefits in many patients 5
  • Not considering the higher dose range (100-150 mg) for heart failure patients 2
  • Failing to start with a lower dose (25 mg) in patients at risk for intravascular volume depletion 1
  • Not monitoring renal function and potassium levels, especially when initiating therapy

Remember that while the FDA-approved maximum dose for hypertension is 100 mg daily, clinical trials have shown benefits with doses up to 150 mg daily in specific conditions like heart failure 2.

References

Guideline

Hypertension Management with Losartan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Research

Pharmacokinetic evaluation of losartan.

Expert opinion on drug metabolism & toxicology, 2011

Research

Optimal dose of losartan for renoprotection in diabetic nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.